NVNO - enVVeno Medical Corp

10.72
0.530   4.944%

Share volume: 3,907
Last Updated: 03-03-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$10.19
0.53
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 21%
Liquidity 43%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
7.20%
1 Month
14.16%
3 Months
2,662.89%
6 Months
1,258.85%
1 Year
256.15%
2 Year
63.91%
Key data
Stock price
$10.72
P/E Ratio 
0.00
DAY RANGE
$10.17 - $10.78
EPS 
-$1.08
52 WEEK RANGE
$0.30 - $12.79
52 WEEK CHANGE
$246.37
MARKET CAP 
17.440 M
YIELD 
N/A
SHARES OUTSTANDING 
20.216 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
1.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$15,641
AVERAGE 30 VOLUME 
$19,729
Company detail
CEO: Robert A. Berman
Region: US
Website: envveno.com
Employees: 30
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

enVVeno Medical Corporation focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the. treatment of severe deep venous chronic venous insufficiency.

Recent news